Langford Aili V, Wallis Jason A, Reeve Emily, Buchbinder Rachelle, Cross Amanda J, Turner Justin, Docking Sean, Haas Romi, Johnston Renea V, Ackerman Ilana N, Cyril Sheila, Wale Janet, Gnjidic Danijela, Gorelik Alexandra, O'Connor Denise
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia.
Cochrane Database Syst Rev. 2025 Jul 21;7(7):CD016178. doi: 10.1002/14651858.CD016178.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective is to assess the effects of implementation interventions aimed at improving the uptake of evidence-based opioid deprescribing by healthcare professionals for adults with chronic non-cancer pain, compared with no intervention. The secondary objectives are: To explore whether the effects vary by intervention type (e.g. audit and feedback), target (e.g. healthcare organisations), setting of implementation intervention (e.g. primary care) and duration of opioid use (e.g. < 12 months, ≥ 12 months). To summarise the availability and principal findings of eligible economic evaluations of the implementation interventions.
这是一项Cochrane系统评价(干预措施)的方案。目标如下:主要目标是评估与无干预措施相比,旨在提高医护人员对慢性非癌性疼痛成人患者进行循证阿片类药物减药的实施干预措施的效果。次要目标是:探讨效果是否因干预类型(如审核与反馈)、目标对象(如医疗机构)、实施干预的环境(如初级保健)以及阿片类药物使用时长(如<12个月、≥12个月)而有所不同。总结实施干预措施的合格经济评估的可得性及主要结果。